Yahoo Web Search

Search results

  1. The National University Cancer Institute, Singapore is a national specialist centre under the National University Health System that treats both paediatric and adult cancers.

    • Appointments

      Appointments - NCIS | National University Cancer Institute,...

    • Find a Doctor

      Find a Doctor - NCIS | National University Cancer Institute,...

    • Find Directions

      By Bus. Route 1 From bus stop along Ayer Rajah Expressway...

    • Our Facilities

      breast_surgery@nuhs.edu.sg. Location NUH Medical Centre,...

  2. The National University Cancer Institute, Singapore (NCIS) is a national specialist centre under the National University Health System (NUHS). It is the only public cancer centre in Singapore treating both paediatric and adult cancers in one facility.

  3. National University Cancer Institute, Singapore. Address: NUH Medical Centre (NUHMC) @ Levels 8-10 5 Lower Kent Ridge Road Singapore 119074. Opening Hours: 8.30am to 5.30pm (Mondays - Fridays) Closed on Weekends & Public Holidays. Website: http://www.ncis.com.sg.

  4. The National Childhood Immunisation Schedule (NCIS) comprises childhood vaccinations recommended as the standard of care for protection against vaccine preventable diseases that are of significant healthcare burden to Singapore or would be so without these vaccinations.

  5. The National University Cancer Institute, Singapore (NCIS) is a national specialist centre under the National University Health System (NUHS), and is the only public cancer centre in Singapore that treats both paediatric and adult cancers in one facility.

  6. National Childhood Immunisation Schedule (NCIS) (From birth to age 17 years, effective from 1 November 2020) One or two doses for children and adolescents age 2-17 years with specific medical condition or indication. 6 months to <5 years (6-59 months). adolescents age 5-17 years with specific medical condition or indication. 6 months to <5 ...

  7. A new treatment treats cancer patients with modified T cells. A two-year trial at NCIS in Singapore will test this new therapy on nine to 18 patients who have lymphoma, multiple myeloma, colorectal cancer, lung cancer and liver cancer.